10-Q/A

NABI BIOPHARMACEUTICALS

Company: Vaxart, Inc.
Filed: October 29, 2003
Period of Report: September 27, 2003
Accession Number: 0000950144-03-011967

View Document ↗ View on SEC.gov ↗